Imricor Medical Systems Inc (IMR) - Total Liabilities

Latest as of June 2025: AU$32.49 Million AUD ≈ $22.99 Million USD

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$32.49 Million AUD (≈ $22.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Imricor Medical Systems Inc operating cash flow efficiency to assess how effectively this company generates cash.

Imricor Medical Systems Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Check Imricor Medical Systems Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Imricor Medical Systems Inc Competitors by Total Liabilities

The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.

Company Country Total Liabilities
NationGate Holdings Berhad
KLSE:0270
Malaysia RM1.30 Billion
Beijing Hanbang Technology Corp
SHE:300449
China CN¥157.86 Million
Yunnan luoping Zinc & Electricity Co Ltd
SHE:002114
China CN¥1.40 Billion
Angel Oak Financial Strategies Income Term Trust
NYSE:FINS
USA $127.39 Million
Taiwan Paiho Ltd
TW:9938
Taiwan NT$16.48 Billion
CTOS Digital Bhd
KLSE:5301
Malaysia RM211.19 Million
Meihua International Medical Technologies Co Ltd
NASDAQ:MHUA
USA $25.64 Million
Xinjiang Talimu Agriculture Development Co Ltd
SHG:600359
China CN¥839.80 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IMR market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 26.23 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.58 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imricor Medical Systems Inc (2016–2024)

The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 AU$29.00 Million
≈ $20.52 Million
+69.98%
2023-12-31 AU$17.06 Million
≈ $12.07 Million
+175.61%
2022-12-31 AU$6.19 Million
≈ $4.38 Million
+38.68%
2021-12-31 AU$4.46 Million
≈ $3.16 Million
-6.09%
2020-12-31 AU$4.75 Million
≈ $3.36 Million
+36.27%
2019-12-31 AU$3.49 Million
≈ $2.47 Million
+34.78%
2018-12-31 AU$2.59 Million
≈ $1.83 Million
-68.63%
2017-12-31 AU$8.25 Million
≈ $5.84 Million
+10.08%
2016-12-31 AU$7.50 Million
≈ $5.30 Million
--

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$425.79 Million
AU$601.78 Million AUD
Market Cap Rank
#13391 Global
#340 in Australia
Share Price
AU$1.88
Change (1 day)
-2.34%
52-Week Range
AU$1.20 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more